Cervical cancer in women living with HIV, screening of women living with HIV and management of cancer, and evidence gaps in screening and management has been presented. There are still many questions that should be addressed in future regarding ideal screening interval, primary and triage test for women living with HIV.
Do you have any questions? Contact us via email survey.cascade@gmail.com.
Funding
These activities are part of the project: Cervical Cancer Prevention and Care Cascade for women living with HIV in sub-Saharan Africa, that has received support from the Swiss Agency for Development and Cooperation; grant Advancing Cervical Cancer Screening in HIV-positive women (ACCHIVe) —The Cervical Cancer Prevention and Care Cascade (Award number: IZP8Z0_180245). The research is also supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD), National Institute Of Diabetes And Digestive And Kidney Diseases (NIDDK), National Heart, Lung, And Blood Institute (NHLBI), National Institute On Alcohol Abuse And Alcoholism (NIAAA), Fogarty International Center (FIC), National Cancer Institute (NCI), and by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number U01AI069924. We acknowledge the funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 801076 and support from the Federal Commission for Scholarships for Foreign Students for the Swiss Government Excellence Scholarship (ESKAS No. 2019.0741). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
